0000059478-20-000187.txt : 20201210
0000059478-20-000187.hdr.sgml : 20201210
20201210170052
ACCESSION NUMBER: 0000059478-20-000187
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201208
FILED AS OF DATE: 20201210
DATE AS OF CHANGE: 20201210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ELI LILLY & Co
CENTRAL INDEX KEY: 0000059478
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
STATE OF INCORPORATION: IN
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39746
FILM NUMBER: 201381297
BUSINESS ADDRESS:
STREET 1: LILLY CORPORATE CTR
STREET 2: DROP CODE 1094
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
BUSINESS PHONE: 3172762000
MAIL ADDRESS:
STREET 1: LILLY CORPORATE CENTER
STREET 2: DROP CODE 1094
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
FORMER NAME:
FORMER CONFORMED NAME: LILLY ELI & CO
DATE OF NAME CHANGE: 19941024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sigilon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001821323
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474005543
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 BINNEY STREET
STREET 2: STE 600
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-336-7540
MAIL ADDRESS:
STREET 1: 100 BINNEY STREET
STREET 2: STE 600
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
wf-form4_160763763834444.xml
FORM 4
X0306
4
2020-12-08
1
0001821323
Sigilon Therapeutics, Inc.
SGTX
0000059478
ELI LILLY & Co
LILLY CORPORATE CENTER
INDIANAPOLIS
IN
46285
0
0
1
0
Common Stock
2020-12-08
4
C
0
2444443
A
2444443
D
Common Stock
2020-12-08
4
P
0
300000
18
A
2744443
D
Series A-3 Convertible Preferred Stock
2020-12-08
4
C
0
1555555
D
Common Stock
1555555.0
0
D
Series B Convertible Preferred Stock
2020-12-08
4
C
0
888888
D
Common Stock
888888.0
0
D
Upon the closing of the Issuer's initial public offering, each share of Series A-3 Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, the "Preferred Stock") automatically converted into shares of the Issuer's common stock without payment or further consideration. There was no expiration date for the Preferred Stock. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer.
Erin Conway, Assistant Secretary
2020-12-10